Device Radiology

Livermultiscan

Payments companies reported to CMS as associated with Livermultiscan. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$2.0Massociated payments (2023-2025)
112clinicians with associated payments
1company reporting

By year

2023 $900K
2024 $1.1M
2025 $4,534

Payments reported as associated with Livermultiscan, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Diagnostic Radiology $942K
Anatomic Pathology & Clinical Pathology $533K
Gastroenterology (Internal Medicine) $401K
Emergency Medicine $67K
Anatomic Pathology $16K
Surgical $12K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Livermultiscan

These are the largest totals companies reported as associated with Livermultiscan. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Mukesh Harisinghani Boston, MA Diagnostic Radiology $712,148.03
Meng Che Yeh Seattle, WA Anatomic Pathology & Clinical Pathology $488,792.12
Naim Alkhouri Westlake, OH Gastroenterology (Internal Medicine) $170,724.89
Fatih Akisik Indianapolis, IN Diagnostic Radiology $146,756.87
Joel Brill Paradise Valley, AZ Gastroenterology (Internal Medicine) $96,000.00
Stephen Harrison Live Oak, TX Gastroenterology (Internal Medicine) $88,037.63
Lawrence Tanenbaum New York, NY Diagnostic Radiology $81,990.39
Elizabeth Fagan Mckinney, TX Emergency Medicine $67,232.16
Mazen Noureddin Houston, TX Gastroenterology (Internal Medicine) $41,666.65
Danielle Carpenter Saint Louis, MO Anatomic Pathology & Clinical Pathology $27,282.42

Prescribed Livermultiscan?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.